Amphotericin B Powder
Description
Amphotericin B Powder - High-Purity Antifungal API for Pharmaceutical & Research Applications
Xi'an Le-Nutra Ingredients Inc. provides pharmaceutical-grade Amphotericin B Powder with purity ≥99%, manufactured in a certified 60,000㎡ GMP production facility with 3,000 tons annual capacity. Our product meets stringent USP/EP standards with complete batch documentation including COA, TDS, MSDS, and HPLC chromatograms. Backed by 14+ years of expertise in active pharmaceutical ingredient production, we offer low endotoxin grade (<5 EU/mg) suitable for injectable formulations, cell culture supplements, and advanced liposomal delivery systems. Each batch undergoes rigorous quality control with 12-month retention for re-inspection, ensuring consistent quality for global pharmaceutical manufacturers and research institutions.

What Is Amphotericin B and Its Pharmaceutical Significance?
Amphotericin B represents a polyene macrolide antibiotic with broad-spectrum antifungal activity against life-threatening systemic mycoses. This yellow to orange powder addresses critical clinical challenges in treating invasive fungal infections caused by Candida, Aspergillus, Cryptococcus, and Mucor species.
Unlike narrow-spectrum azole agents, this compound binds selectively to ergosterol in fungal cell membranes, creating pore formations that disrupt cellular integrity. The molecular formula C₄₇H₇₃NO₁₇ with molecular weight 924.08 ensures precise pharmacological action.
For pharmaceutical manufacturers, our material solves key formulation challenges. Traditional deoxycholate formulations face nephrotoxicity concerns, while our high-purity powder enables development of lipid-based delivery systems that significantly reduce adverse effects. Research-grade applications benefit from consistent potency and minimal endotoxin contamination.
Technical Specifications and Quality Parameters
| Parameter | Specification |
|---|---|
| Product Name | Amphotericin B Powder |
| CAS Number | 1397-89-3 |
| Molecular Formula | C₄₇H₇₃NO₁₇ |
| Molecular Weight | 924.08 g/mol |
| Appearance | Yellow to orange powder |
| Purity (HPLC) | ≥99% |
| Loss on Drying | ≤5% |
| Residue on Ignition | ≤0.5% |
| Heavy Metals | ≤20 ppm |
| Total Plate Count | ≤10 cfu/g |
| Yeast & Mold | ≤100 cfu/g |
Pharmaceutical Advantages for Modern Formulation Development
Our substance provides three key competitive benefits for pharmaceutical developers. Firstly, the activity against a number of genera of fungi makes the drug a first line intervention in serious systemic infections, when delay in therapy is associated with increased mortality.
Second, the compatibility with novel delivery systems can change the therapeutic outcomes. Conventional formulations have raised concerns of nephrotoxicity but our pharmaceutical grade powder facilitates liposomal encapsulation and lipid complex formulations that improve the therapeutic index. This will allow the creation of safer intravenous medicines that patients can better tolerate.
Thirdly, the dual functionality has applications in therapy and prevention. Low quantities are beneficial not only in treating established infections but also in preventing fungal contamination of cell culture systems. Biopharmaceutical makers use this feature to keep biologics sterile throughout synthesis.
Application Scenarios Across Pharmaceutical and Research Sectors
Injectable Pharmaceutical Formulations: Your development teams can prepare classic amphotericin B deoxycholate injections or sophisticated lipid-based systems. The low endotoxin specification meets the requirements for parenteral administration and the high purity decreases the negative effects connected to the excipient.
Cell Culture and Biomanufacturing: 2.5-5 μg/mL added to culture media reduces fungal contamination and does not influence mammalian cell viability. This protects valuable bioreactor runs and guarantees product consistency for the manufacturing of monoclonal antibodies and vaccines.
Applications of Research Tool: This substance is used by researchers to explore the mechanisms of polyene antibiotics, the dynamics of membrane permeability and the paths of fungal resistance. The specified purity allows reliable experimental results from one laboratory to another.
Liposomal and Lipid Complex Development: Your formulation scientists can use this material to develop next-generation delivery methods that encapsulate the medicine in lipid vesicles, greatly lowering tissue toxicity, while retaining antifungal activity.
Complete Quality Assurance and Documentation Support
All production batches are tested analytically fully before release. HPLC analysis shows purity > 99% and structure is verified by spectroscopic techniques. Heavy metal screening guarantees pharmaceutical safety limits.
You get comprehensive paperwork to assist regulatory submissions. The Certificate of Analysis provides all specification parameters with real test results. Technical Data Sheets, containing usage guidelines and stability information. Occupational safety is assured by Material Safety Data Sheets.
HPLC chromatograms indicate that the peaks are pure and no degradation products are present. Endotoxin testing data confirm levels below 5 EU/mg for injectable grade criteria. All paperwork is ICH compliant and allows DMF submissions.
The 12-month batch retention provides retrospective testing if any problems occur during the formulation development or stability investigations. This traceability assists your quality management systems and regulatory audit obligations.

Flexible Customization for Research Through Commercial Production
We know that different stages of a project need varied quantities and requirements. Cost reduction in early-stage research with 1kg packs in feasibility studies. The 5kg or 10kg volumes are useful for mid-scale development while you optimise formulations and do preclinical testing.
Commercial manufacture: the product is packed in 25kg fibre drums, lined with pharmaceutical grade polythene bags. This container protects the Amphotericin B Powder from moisture and allows for effective material handling in production situations.
We have custom packaging and private label services to support your brand needs. We accept various delivery terms such as EXW, FOB, CFR, CIF, DAP, DDP, etc, in an effort to facilitate international logistics. Low minimum order quantities starting at 1kg eliminate hurdles in early assessment phases.
Specification customisation for distinct application requirements. If your cell culture techniques require ultra-low endotoxin grades or precise particle size distributions, our R&D team creates customised solutions with validation data.
Storage and Stability Guidelines for Maximum Shelf Life
To preserve the efficacy of your item for the full 5-year shelf life, store it properly. Store in original packaging at 2-8°C to avoid thermal degradation. It must be protected from light as ultraviolet radiation increases degradation of the polyene structure.
The best place to store items for more than 6 months is in the freezer at -20 C. Keep containers securely closed to prevent absorption of moisture which causes hydrolysis and loss of effectiveness. Hygroscopic – Requires desiccant packs in storage regions.
Minimise exposure to air during the transfer of the material for formulation to prevent oxidative deterioration. After opening, use within appropriate periods or transfer to amber glass containers in inert atmosphere. These measures keep the yellow-orange colour and biological activity.
Temperature excursions during shipping are controlled with approved cold chain logistics. We partner with specialised pharmaceutical carriers to arrange transit and use insulated packaging and temperature monitors to assure product integrity upon arrival.
Packaging Options for Different Order Volumes
Standard commercial packaging is 25kg fibre drums with double layer food grade polyethylene liners. This arrangement prevents the admission of moisture and light during storage and travel. drums are labelled with batch numbers, manufacture dates and storage directions.
Research and development quantities are available in 1kg, 5kg and 10kg. Smaller packages reduce formulation optimisation waste and allow numerous simultaneous tests. All packaging materials are tested for extractables and are within pharmaceutical container requirements.
FAQ
Q: What makes this powder suitable for liposomal formulations compared to standard grades?
A: We offer a pharmaceutical grade material with a regulated particle size distribution and low endotoxin levels which are required for parenteral goods. The high purity removes contaminants that interfere with the production of lipid bilayers. Encapsulating the medicine in liposomes retains the pharmacological action, and the lipid carrier decreases the toxicity to tissues by changing the biodistribution patterns away from the kidneys.
Q: How do you maintain batch-to-batch uniformity for commercial manufacturing?
A: In our 60,000 square metre plant, we use statistical process control on six production lines. Validated SOPs govern raw material qualification, in-process monitoring and final testing. Comparative analysis between batches is enabled using retention samples. 98% on-time delivery. Our supply chain consistency supports your production schedules.
Q: Could this substance be employed in combination antifungal therapies?
A: Yes, it demonstrates synergistic activity with azole antifungals and echinocandins in research models. The dual modes of action (membrane rupture versus ergosterol synthesis suppression) are complimentary. Your clinical development teams should perform suitable compatibility and stability investigations for specific combination formulations.
Q: What analytical methods are used to confirm the purity specification?
A: The parent compound is determined by HPLC with UV detection (406nm) against certified reference standards. Methods are validated according to ICH Q2 requirements and specificity experiments confirmed separation from degradation products. Confirmation of molecular weight by mass spectrometry. Optical rotations measurements confirm stereochemical integrity of the molecule.
Q: Are your production capacities adequate for R&D and commercial needs?
A: We have 3,000 tonnes per year that allows us to flexibly schedule over a wide range of ingredient categories. Small research quantities ship within days. Commercial orders have more than a 30 day safety stock. The scale-up procedure from lab to production is consistent in manufacturing characteristics. Formulations made with research samples will perform the same at commercial size.

Partner With a Reliable API Manufacturer
Ready to secure a consistent supply of pharmaceutical-grade Amphotericin B Powder for your formulation projects? Contact us at enquiry@lenutra.com to request samples, discuss custom specifications, or place your order today.
Online Message
YOU MAY LIKE
High-quality Botanical Extracts, Functional Ingredients, And Nutraceutical Raw Materials Manufacturer And Supplier